1. Caveolin-1, cancer and therapy resistance
   Julia Ketteler et al, 2018, Int. J. Cancer CrossRef
2. Caveolin-1 as a target in prevention and treatment of hypertrophic scarring
   Ilja L. Kruglikov et al, 2019, npj Regen Med CrossRef
3. Caveolin as a Universal Target in Dermatology
   Ilja L. Kruglikov et al, 2019, IJMS CrossRef
4. Caveolin-1 Promotes Chemoresistance of Gastric Cancer Cells to Cisplatin by Activating WNT/β-Catenin Pathway.
   Xi Wang et al, 2020, Front Oncol CrossRef
5. Multifaceted Roles of Caveolin-1 in Lung Cancer: A New Investigation Focused on Tumor Occurrence, Development and Therapy
   Yu-Bo Shi et al, 2020, Cancers CrossRef
6. Overexpression of lamin B1 induces mitotic catastrophe in colon cancer LoVo cells and is associated with worse clinical outcomes
   Magdalena Izdebska et al, 2017, Int J Oncol CrossRef
7. The role of caveolin-1 in the biofate and efficacy of anti-tumor drugs and their nano-drug delivery systems
   Canyu Yang et al, 2020, Acta Pharmaceutica Sinica B CrossRef
8. Identification of Key Gene Targets for Sensitizing Colorectal Cancer to Chemoradiation: an Integrative Network Analysis on Multiple Transcriptomics Data
   Hamed Manoochehri et al, 2021, J Gastrointest Canc CrossRef
9. Prognostic significance and therapeutic implications of Caveolin-1 in gastrointestinal tract malignancies
   Konstantinos Kamposioras et al, 2021, Pharmacology & Therapeutics CrossRef
10. Photoresponsive prodrug‐dye nanoassembly for in‐situ monitorable cancer therapy
    Kaiqi Long et al, 2022, Bioengineering & Transla Med CrossRef
11. Smart Fe3O4@ZnO Core-Shell Nanophotosensitizers Potential for Combined Chemo and Photodynamic Skin Cancer Therapy Controlled by UVA Radiation
    Qian Ren et al, 2022, IJN CrossRef
12. 20(S)‐Protopanaxadiol saponins isolated from Panax notoginseng target caveolin‐1 against intestinal barrier dysfunction by alleviating inflammatory injury and oxidative stress in experimental murine colitis
    Pengde Lu et al, 2023, Food Frontiers CrossRef
13. Treatment strategies and drug resistance mechanisms in adenocarcinoma of different organs
    Peng Xing et al, 2023, Drug Resistance Updates CrossRef